Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.

Quantitative assessment of renal structural and functional changes in chronic kidney disease using multi-parametric magnetic resonance imaging.

Buchanan CE, Mahmoud H, Cox EF, McCulloch T, Prestwich BL, Taal MW, Selby NM, Francis ST.

Nephrol Dial Transplant. 2019 Jun 29. pii: gfz129. doi: 10.1093/ndt/gfz129. [Epub ahead of print]

PMID:
31257440
2.

Biological variation of measured and estimated glomerular filtration rate in patients with chronic kidney disease.

Rowe C, Sitch AJ, Barratt J, Brettell EA, Cockwell P, Dalton RN, Deeks JJ, Eaglestone G, Pellatt-Higgins T, Kalra PA, Khunti K, Loud FC, Morris FS, Ottridge RS, Stevens PE, Sharpe CC, Sutton AJ, Taal MW, Lamb EJ; eGFR-C study group.

Kidney Int. 2019 Mar 7. pii: S0085-2538(19)30274-1. doi: 10.1016/j.kint.2019.02.021. [Epub ahead of print]

PMID:
31084924
3.

Sodium and water handling during hemodialysis: new pathophysiologic insights and management approaches for improving outcomes in end-stage kidney disease.

Canaud B, Kooman J, Selby NM, Taal M, Francis S, Kopperschmidt P, Maierhofer A, Kotanko P, Titze J.

Kidney Int. 2019 Feb;95(2):296-309. doi: 10.1016/j.kint.2018.09.024. Review.

PMID:
30665570
4.

Feasibility and effectiveness of pre-emptive rehabilitation in persons approaching dialysis (PREHAB).

Willingham FC, Speelman I, Hamilton J, von Fragstein G, Shaw S, Taal MW.

J Ren Care. 2019 Mar;45(1):9-19. doi: 10.1111/jorc.12262. Epub 2019 Jan 16.

PMID:
30648345
5.

Long-term outcomes after AKI-a major unmet clinical need.

Selby NM, Taal MW.

Kidney Int. 2019 Jan;95(1):21-23. doi: 10.1016/j.kint.2018.09.005.

PMID:
30606416
6.

The Association of Nutritional Factors and Skin Autofluorescence in Persons Receiving Hemodialysis.

Viramontes Hörner D, Selby NM, Taal MW.

J Ren Nutr. 2019 Mar;29(2):149-155. doi: 10.1053/j.jrn.2018.07.004. Epub 2018 Oct 8.

PMID:
30309781
7.

Magnetic resonance imaging biomarkers for chronic kidney disease: a position paper from the European Cooperation in Science and Technology Action PARENCHIMA.

Selby NM, Blankestijn PJ, Boor P, Combe C, Eckardt KU, Eikefjord E, Garcia-Fernandez N, Golay X, Gordon I, Grenier N, Hockings PD, Jensen JD, Joles JA, Kalra PA, Krämer BK, Mark PB, Mendichovszky IA, Nikolic O, Odudu A, Ong ACM, Ortiz A, Pruijm M, Remuzzi G, Rørvik J, de Seigneux S, Simms RJ, Slatinska J, Summers P, Taal MW, Thoeny HC, Vallée JP, Wolf M, Caroli A, Sourbron S.

Nephrol Dial Transplant. 2018 Sep 1;33(suppl_2):ii4-ii14. doi: 10.1093/ndt/gfy152.

8.

Personalized medicine in nephrology: a novel approach or just good medicine?

Taal MW.

Curr Opin Nephrol Hypertens. 2018 Nov;27(6):395-397. doi: 10.1097/MNH.0000000000000448. No abstract available.

PMID:
30095481
9.

What every doctor needs to know about chronic kidney disease.

Kazmi I, Gullapudi L, Taal MW.

Br J Hosp Med (Lond). 2018 Aug 2;79(8):438-443. doi: 10.12968/hmed.2018.79.8.438.

PMID:
30070954
10.

Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney Disease.

Haynes R, Judge PK, Staplin N, Herrington WG, Storey BC, Bethel A, Bowman L, Brunskill N, Cockwell P, Hill M, Kalra PA, McMurray JJV, Taal M, Wheeler DC, Landray MJ, Baigent C.

Circulation. 2018 Oct 9;138(15):1505-1514. doi: 10.1161/CIRCULATIONAHA.118.034818.

PMID:
30002098
11.

What is the value of multidisciplinary care for chronic kidney disease?

Fluck RJ, Taal MW.

PLoS Med. 2018 Mar 27;15(3):e1002533. doi: 10.1371/journal.pmed.1002533. eCollection 2018 Mar.

12.

Impact of pentavalent rotavirus vaccine against severe rotavirus diarrhoea in The Gambia.

Sanneh B, Papa Sey A, Shah M, Tate J, Sonko M, Jagne S, Jarju M, Sowe D, Taal M, Cohen A, Parashar U, Mwenda JM.

Vaccine. 2018 Nov 12;36(47):7179-7184. doi: 10.1016/j.vaccine.2018.02.091. Epub 2018 Mar 12.

PMID:
29544688
13.

The Association of Serum Free Light Chains With Mortality and Progression to End-Stage Renal Disease in Chronic Kidney Disease: Systematic Review and Individual Patient Data Meta-analysis.

Fraser SDS, Fenton A, Harris S, Shardlow A, Liabeuf S, Massy ZA, Burmeister A, Hutchison CA, Landray M, Emberson J, Kalra PA, Ritchie JP, Cockwell P, Taal MW.

Mayo Clin Proc. 2017 Nov;92(11):1671-1681. doi: 10.1016/j.mayocp.2017.08.021. Epub 2017 Nov 1. Review. Erratum in: Mayo Clin Proc. 2017 Dec;92 (12 ):1866. Kalra, Phil [corrected to Kalra, Phil A].

PMID:
29101935
14.

Effect of weekend admission on mortality associated with severe acute kidney injury in England: A propensity score matched, population-based study.

Kolhe NV, Fluck RJ, Taal MW.

PLoS One. 2017 Oct 10;12(10):e0186048. doi: 10.1371/journal.pone.0186048. eCollection 2017.

15.

The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study.

Shardlow A, McIntyre NJ, Fraser SDS, Roderick P, Raftery J, Fluck RJ, McIntyre CW, Taal MW.

PLoS Med. 2017 Oct 10;14(10):e1002400. doi: 10.1371/journal.pmed.1002400. eCollection 2017 Oct.

16.

Multiparametric Renal Magnetic Resonance Imaging: Validation, Interventions, and Alterations in Chronic Kidney Disease.

Cox EF, Buchanan CE, Bradley CR, Prestwich B, Mahmoud H, Taal M, Selby NM, Francis ST.

Front Physiol. 2017 Sep 14;8:696. doi: 10.3389/fphys.2017.00696. eCollection 2017.

17.

Sodium MRI: a new frontier in imaging in nephrology.

Francis S, Buchanan CE, Prestwich B, Taal MW.

Curr Opin Nephrol Hypertens. 2017 Nov;26(6):435-441. doi: 10.1097/MNH.0000000000000370. Review.

PMID:
28877041
18.
19.

Patients' Experiences After CKD Diagnosis: A Meta-ethnographic Study and Systematic Review.

Teasdale EJ, Leydon G, Fraser S, Roderick P, Taal MW, Tonkin-Crine S.

Am J Kidney Dis. 2017 Nov;70(5):656-665. doi: 10.1053/j.ajkd.2017.05.019. Epub 2017 Jul 29. Review.

PMID:
28764920
20.

Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR<45 mL/min/1.73 m2): a summary document from the European Renal Best Practice Group.

Farrington K, Covic A, Nistor I, Aucella F, Clyne N, De Vos L, Findlay A, Fouque D, Grodzicki T, Iyasere O, Jager KJ, Joosten H, Macias JF, Mooney A, Nagler E, Nitsch D, Taal M, Tattersall J, Stryckers M, van Asselt D, Van den Noortgate N, van der Veer S, van Biesen W.

Nephrol Dial Transplant. 2017 Jan 1;32(1):9-16. doi: 10.1093/ndt/gfw411.

21.

Formula to detect high sodium excretion from spot urine in chronic kidney disease patients.

Nerbass FB, Hallvass AE, Taal MW, Pecoits-Filho R.

J Bras Nefrol. 2017 Mar;39(1):23-28. doi: 10.5935/0101-2800.20170004. Portuguese, English.

22.

Intradialytic Cardiac Magnetic Resonance Imaging to Assess Cardiovascular Responses in a Short-Term Trial of Hemodiafiltration and Hemodialysis.

Buchanan C, Mohammed A, Cox E, Köhler K, Canaud B, Taal MW, Selby NM, Francis S, McIntyre CW.

J Am Soc Nephrol. 2017 Apr;28(4):1269-1277. doi: 10.1681/ASN.2016060686. Epub 2016 Nov 10.

23.

Chronic kidney disease: towards a risk-based approach.

Taal MW.

Clin Med (Lond). 2016 Dec;16(Suppl 6):s117-s120. Review.

24.

Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR <45 mL/min/1.73 m2).

Farrington K, Covic A, Aucella F, Clyne N, de Vos L, Findlay A, Fouque D, Grodzicki T, Iyasere O, Jager KJ, Joosten H, Macias JF, Mooney A, Nitsch D, Stryckers M, Taal M, Tattersall J, Van Asselt D, Van den Noortgate N, Nistor I, Van Biesen W; ERBP guideline development group.

Nephrol Dial Transplant. 2016 Nov;31(suppl 2):ii1-ii66. No abstract available.

PMID:
27807144
25.

A simple care bundle for use in acute kidney injury: a propensity score-matched cohort study.

Kolhe NV, Reilly T, Leung J, Fluck RJ, Swinscoe KE, Selby NM, Taal MW.

Nephrol Dial Transplant. 2016 Nov;31(11):1846-1854. Epub 2016 May 4.

PMID:
27190331
26.

Regional Variation in Acute Kidney Injury Requiring Dialysis in the English National Health Service from 2000 to 2015 - A National Epidemiological Study.

Kolhe NV, Fluck RJ, Muirhead AW, Taal MW.

PLoS One. 2016 Oct 17;11(10):e0162856. doi: 10.1371/journal.pone.0162856. eCollection 2016.

27.

Multimorbidity in people with chronic kidney disease: implications for outcomes and treatment.

Fraser SD, Taal MW.

Curr Opin Nephrol Hypertens. 2016 Nov;25(6):465-472. Review.

PMID:
27490909
28.

Chronic Kidney Disease in Primary Care: Outcomes after Five Years in a Prospective Cohort Study.

Shardlow A, McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW.

PLoS Med. 2016 Sep 20;13(9):e1002128. doi: 10.1371/journal.pmed.1002128. eCollection 2016 Sep.

29.

International Criteria for Acute Kidney Injury: Advantages and Remaining Challenges.

Selby NM, Fluck RJ, Kolhe NV, Taal MW.

PLoS Med. 2016 Sep 13;13(9):e1002122. doi: 10.1371/journal.pmed.1002122. eCollection 2016 Sep.

30.

Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study.

Lemoine M, Shimakawa Y, Njie R, Taal M, Ndow G, Chemin I, Ghosh S, Njai HF, Jeng A, Sow A, Toure-Kane C, Mboup S, Suso P, Tamba S, Jatta A, Sarr L, Kambi A, Stanger W, Nayagam S, Howell J, Mpabanzi L, Nyan O, Corrah T, Whittle H, Taylor-Robinson SD, D'Alessandro U, Mendy M, Thursz MR; PROLIFICA investigators.

Lancet Glob Health. 2016 Aug;4(8):e559-67. doi: 10.1016/S2214-109X(16)30130-9.

31.

Where now for proteinuria testing in chronic kidney disease?: Good evidence can clarify a potentially confusing message.

Fraser SD, Roderick PJ, Taal MW.

Br J Gen Pract. 2016 Apr;66(645):215-7. doi: 10.3399/bjgp16X684721. No abstract available.

32.

The epidemiology of hospitalised acute kidney injury not requiring dialysis in England from 1998 to 2013: retrospective analysis of hospital episode statistics.

Kolhe NV, Muirhead AW, Wilkes SR, Fluck RJ, Taal MW.

Int J Clin Pract. 2016 Apr;70(4):330-9. doi: 10.1111/ijcp.12774. Epub 2016 Jan 22.

33.

Regarding the open ring-shaped guider for a continuous curvilinear capsulorhexis.

Ni Dhubhghaill SS, Taal M, Tassignon MJ.

J Cataract Refract Surg. 2015 Nov;41(11):2592. doi: 10.1016/j.jcrs.2015.10.065. No abstract available.

PMID:
26703520
34.

Optical Coherence Tomography in Cultivated Limbal Epithelial Stem Cell Transplantation Surgery.

Zakaria N, Ní Dhubhghaill S, Taal M, Berneman Z, Koppen C, Tassignon MJ.

Asia Pac J Ophthalmol (Phila). 2015 Nov-Dec;4(6):339-45. doi: 10.1097/APO.0000000000000163.

PMID:
26649762
35.

Hepatitis E virus infection and acute-on-chronic liver failure in West Africa: a case-control study from The Gambia.

Shimakawa Y, Njai HF, Takahashi K, Berg L, Ndow G, Jeng-Barry A, Ceesay A, Tamba S, Opoku E, Taal M, Akbar SM, Arai M, D'Alessandro U, Taylor-Robinson SD, Njie R, Mishiro S, Thursz MR, Lemoine M.

Aliment Pharmacol Ther. 2016 Feb;43(3):375-84. doi: 10.1111/apt.13484. Epub 2015 Dec 1.

36.

The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study.

Fraser SD, Roderick PJ, May CR, McIntyre N, McIntyre C, Fluck RJ, Shardlow A, Taal MW.

BMC Nephrol. 2015 Dec 1;16:193. doi: 10.1186/s12882-015-0189-z.

37.

Correction: The Association between Polyclonal Combined Serum Free Light Chain Concentration and Mortality in Individuals with Early Chronic Kidney Disease.

Assi LK, McIntyre N, Fraser S, Harris S, Hutchison CA, McIntyre CW, Cockwell P, Taal MW.

PLoS One. 2015 Oct 20;10(10):e0141404. doi: 10.1371/journal.pone.0141404. eCollection 2015. No abstract available.

38.

Chronic kidney disease in older people - diagnosis, aetiology and consequences.

Taal MW.

Curr Opin Nephrol Hypertens. 2015 Nov;24(6):475-9. doi: 10.1097/MNH.0000000000000164. Review.

PMID:
26371527
39.

Long Term Outcomes after Acute Kidney Injury: Lessons from the ARID Study.

Horne KL, Shardlow A, Taal MW, Selby NM.

Nephron. 2015;131(2):102-6. doi: 10.1159/000439066. Epub 2015 Sep 5. Review.

40.

Reduction in sodium intake is independently associated with improved blood pressure control in people with chronic kidney disease in primary care.

Nerbass FB, Pecoits-Filho R, McIntyre NJ, Shardlow A, McIntyre CW, Taal MW.

Br J Nutr. 2015 Sep 28;114(6):936-42. doi: 10.1017/S0007114515002494. Epub 2015 Aug 5.

PMID:
26243465
41.

National trends in acute kidney injury requiring dialysis in England between 1998 and 2013.

Kolhe NV, Muirhead AW, Wilkes SR, Fluck RJ, Taal MW.

Kidney Int. 2015 Nov;88(5):1161-9. doi: 10.1038/ki.2015.234. Epub 2015 Jul 29.

PMID:
26221750
42.

Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia.

Shimakawa Y, Lemoine M, Njai HF, Bottomley C, Ndow G, Goldin RD, Jatta A, Jeng-Barry A, Wegmuller R, Moore SE, Baldeh I, Taal M, D'Alessandro U, Whittle H, Njie R, Thursz M, Mendy M.

Gut. 2016 Dec;65(12):2007-2016. doi: 10.1136/gutjnl-2015-309892. Epub 2015 Jul 16.

43.

Impact of Compliance with a Care Bundle on Acute Kidney Injury Outcomes: A Prospective Observational Study.

Kolhe NV, Staples D, Reilly T, Merrison D, Mcintyre CW, Fluck RJ, Selby NM, Taal MW.

PLoS One. 2015 Jul 10;10(7):e0132279. doi: 10.1371/journal.pone.0132279. eCollection 2015.

44.

Risk factors: The kidneys find a voice in cardiovascular risk prediction.

Taal MW.

Nat Rev Nephrol. 2015 Sep;11(9):510-2. doi: 10.1038/nrneph.2015.109. Epub 2015 Jul 7. No abstract available.

PMID:
26149837
45.

The Association between Polyclonal Combined Serum Free Light Chain Concentration and Mortality in Individuals with Early Chronic Kidney Disease.

Assi LK, McIntyre N, Fraser S, Harris S, Hutchison CA, McIntyre CW, Cockwell P, Taal MW.

PLoS One. 2015 Jul 1;10(7):e0129980. doi: 10.1371/journal.pone.0129980. eCollection 2015. Erratum in: PLoS One. 2015;10(10):e0141404.

46.

The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa.

Lemoine M, Shimakawa Y, Nayagam S, Khalil M, Suso P, Lloyd J, Goldin R, Njai HF, Ndow G, Taal M, Cooke G, D'Alessandro U, Vray M, Mbaye PS, Njie R, Mallet V, Thursz M.

Gut. 2016 Aug;65(8):1369-76. doi: 10.1136/gutjnl-2015-309260. Epub 2015 Jun 24.

47.

PROLIFICA: a story of West African clinical and research collaborations to target hepatitis B-related hepatocellular carcinoma in West Africa.

Howell J, Ladep NG, Nayagam S, Lemoine M, Garside DA, Crossey MME, Okeke E, Njie R, Ka MM, Taal M, Thursz MR, Taylor-Robinson SD.

QJM. 2016 Jun;109(6):373-375. doi: 10.1093/qjmed/hcv118. Epub 2015 Jun 22. No abstract available.

48.

Malaria Prevalence among Young Infants in Different Transmission Settings, Africa.

Ceesay SJ, Koivogui L, Nahum A, Taal MA, Okebe J, Affara M, Kaman LE, Bohissou F, Agbowai C, Tolno BG, Amambua-Ngwa A, Bangoura NF, Ahounou D, Muhammad AK, Duparc S, Hamed K, Ubben D, Bojang K, Achan J, D'Alessandro U.

Emerg Infect Dis. 2015 Jul;21(7):1114-21. doi: 10.3201/eid2107.142036.

49.

Intraocular lens exchange technique for an opacified bag-in-the-lens.

Ní Dhubhghaill S, Van Os L, De Keizer RJ, Taal M, Zakaria N, Tassignon MJ.

J Cataract Refract Surg. 2015 May;41(5):924-8. doi: 10.1016/j.jcrs.2015.04.006.

PMID:
26049828
50.

Birth order and risk of hepatocellular carcinoma in chronic carriers of hepatitis B virus: a case-control study in The Gambia.

Shimakawa Y, Lemoine M, Bottomley C, Njai HF, Ndow G, Jatta A, Tamba S, Bojang L, Taal M, Nyan O, D'Alessandro U, Njie R, Thursz M, Hall AJ.

Liver Int. 2015 Oct;35(10):2318-26. doi: 10.1111/liv.12814. Epub 2015 Mar 11.

PMID:
25728498

Supplemental Content

Support Center